Taken together, our findings reveal a multifactorial interplay in cervical cancer progression, in which viral oncogenesis (via HPV), immune signaling (STAT3/NF‐κB), cellular players (M2‐TAMs, Tregs), and host genetic background (FOXP3 and HLA‐G polymorphisms) operate in concert to drive immune escape and worsen clinical outcomes. The gene discussed is STAT3; the disease is cervical cancer.